Find out more about which tumor types are being studied in currently enrolling late-stage clinical trials.
Learn more about some of the immune signals and pathways tumors exploit to avoid an immune response.
Discover a broad range of development platforms such as small molecules and bispecific antibodies.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.